Sichenzia Ross Ference represented BriaCell Therapeutics Corp. in the transaction.BriaCell Therapeutics Corp. (NASDAQ: BCTX, BCTXW; TSXV: BCT) executed a public offering of 4,852,353 common units at a…
BriaCell Therapeutics Corp.’s $25 Million Common Stock Offering

























